CSIMarket
 


Amgen Inc   (AMGN)
Other Ticker:  
 
 
 

AMGN's vs. Competition, Revenue Growth by Segments

(Revenue Q 3 Growth Rates)



COMPANY NAME TICKER SEGMENT NAME Rev. Y / Y Rev. SEQ.
Amgen Inc AMGN Aranesp 4.01 % -29.77 %
Actavis Plc ACT Generic pharmaceutical products -90.63 % -90.56 %
HOSPIRA, INC. HSP Injectable Pharmaceutical - -
APROX. MARKET   SUBTOTAL -69.41 % -72.25 %
COMPANY NAME TICKER SEGMENT NAME Rev. Y / Y Rev. SEQ.
Amgen Inc AMGN ENBREL 30.27 % 8.23 %
Abbvie Inc ABBV HUMIRA 12.04 % 3.11 %
Abbott Laboratories ABT Established Pharmaceutical Products 24.64 % -1.64 %
Allergan plc AGN Eye Care Pharmaceuticals - -
Biogen Inc BIIB AVONEX - -
Biogen Inc BIIB TYSABRI - -
Biogen Inc BIIB TECFIDERA - -
Biogen Inc BIIB PLEGRIDY - -
Bristol Myers Squibb Co BMY ORENCIA 9.01 % -43.79 %
Johnson and Johnson JNJ REMICADE 83.39 % 95.92 %
Merck and Co Inc MRK Remicade -26.82 % -2.86 %
Pfizer Inc PFE Arthritis & pain -72.25 % -5.36 %
Pfizer Inc PFE All other 223.18 % 105.39 %
APROX. MARKET   SUBTOTAL 69.57 % 45.08 %
COMPANY NAME TICKER SEGMENT NAME Rev. Y / Y Rev. SEQ.
Amgen Inc AMGN EPOGEN TM 88.8 % -0.41 %
Abbvie Inc ABBV HUMIRA 12.04 % 3.11 %
Abbott Laboratories ABT Established Pharmaceutical Products 24.64 % -1.64 %
Actavis Plc ACT Branded pharmaceutical products -4.15 % -36.28 %
Allergan plc AGN Skin Care - -
Bristol Myers Squibb Co BMY ORENCIA 9.01 % -43.79 %
Celgene Corp CELG ABRAXANE 8.34 % -5.86 %
Johnson and Johnson JNJ PROCRIT 77.52 % 97.46 %
Johnson and Johnson JNJ REMICADE 83.39 % 95.92 %
Johnson and Johnson JNJ VELCADE 75.58 % 98.55 %
Eli Lilly And Company LLY Oncology -2.39 % -6.64 %
Eli Lilly And Company LLY Cardiovascular 0.36 % -0.43 %
Merck and Co Inc MRK Zetia -4.09 % -0.31 %
Pfizer Inc PFE Arthritis & pain -72.25 % -5.36 %
Pfizer Inc PFE Oncology -2.79 % -60.87 %
APROX. MARKET   SUBTOTAL 19.33 % 3.5 %
COMPANY NAME TICKER SEGMENT NAME Rev. Y / Y Rev. SEQ.
Amgen Inc AMGN Neulasta 94.72 % 143.76 %
Actavis Plc ACT Generic pharmaceutical products -90.63 % -90.56 %
HOSPIRA, INC. HSP Injectable Pharmaceutical - -
APROX. MARKET   SUBTOTAL -12.59 % -4.07 %
COMPANY NAME TICKER SEGMENT NAME Rev. Y / Y Rev. SEQ.
Amgen Inc AMGN Other product sales - -
Abbvie Inc ABBV HUMIRA 12.04 % 3.11 %
Abbott Laboratories ABT Established Pharmaceutical Products 24.64 % -1.64 %
Bristol Myers Squibb Co BMY Other 56.37 % -
Bristol Myers Squibb Co BMY ORENCIA 9.01 % -43.79 %
Bristol Myers Squibb Co BMY Eliquis 115.74 % -41.16 %
Johnson and Johnson JNJ REMICADE 83.39 % 95.92 %
Eli Lilly And Company LLY Endocrinology 4.57 % 9.07 %
Merck and Co Inc MRK Zocor -8.2 % -11.11 %
Merck and Co Inc MRK CozaarHyzaar -23.08 % -20.63 %
Merck and Co Inc MRK Januvia 2882.35 % -2.87 %
Mylan N v MYL Total 29.33 % 13.64 %
Pfizer Inc PFE Arthritis & pain -72.25 % -5.36 %
Pfizer Inc PFE Cardiovascular & metabolic diseases -49.12 % 40.62 %
APROX. MARKET   SUBTOTAL 22 % 30.01 %
COMPANY NAME TICKER SEGMENT NAME Rev. Y / Y Rev. SEQ.
Amgen Inc AMGN Prolia 25.49 % -5.88 %
APROX. MARKET   SUBTOTAL 25.49 % -5.88 %
COMPANY NAME TICKER SEGMENT NAME Rev. Y / Y Rev. SEQ.
Amgen Inc AMGN Sensipar TM - -
Actavis Plc ACT Branded pharmaceutical products -4.15 % -36.28 %
Bristol Myers Squibb Co BMY SPRYCEL 6.75 % -47.31 %
Celgene Corp CELG ABRAXANE 8.34 % -5.86 %
Johnson and Johnson JNJ PROCRIT 77.52 % 97.46 %
Johnson and Johnson JNJ VELCADE 75.58 % 98.55 %
Eli Lilly And Company LLY Oncology -2.39 % -6.64 %
Eli Lilly And Company LLY Cardiovascular 0.36 % -0.43 %
Merck and Co Inc MRK Zetia -4.09 % -0.31 %
Pfizer Inc PFE Oncology -2.79 % -60.87 %
APROX. MARKET   SUBTOTAL 3.15 % -16.3 %
COMPANY NAME TICKER SEGMENT NAME Rev. Y / Y Rev. SEQ.
Amgen Inc AMGN Vectibix -60.87 % 3.85 %
Celgene Corp CELG ABRAXANE 8.34 % -5.86 %
Johnson and Johnson JNJ VELCADE 75.58 % 98.55 %
Eli Lilly And Company LLY Oncology -2.39 % -6.64 %
Merck and Co Inc MRK Other -12.3 % 8.76 %
Pfizer Inc PFE Oncology -2.79 % -60.87 %
APROX. MARKET   SUBTOTAL -7.21 % 3.92 %



       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

OCDX's Profile

Stock Price

OCDX's Financials

Business Description

Fundamentals

Charts & Quotes

OCDX's News

Suppliers

OCDX's Competitors

Customers & Markets

Economic Indicators

OCDX's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071